Skip to main content

10 New drug combinations to treat breast cancer

Media mentions
23 Dec 16




Communication Officer
Tel.+34 93 40 37255

United Press International publishes an extensive article about the study headed by Patrick Aloy, ICREA researcher and leader of the Structural Bioinformatics and Network Biology Lab at IRB Barcelona.

Published in Cancer Research Journal, the study reveals a new way to fight drug resistance in the treatment of breast cancer through bioinformatics.

Link to UPI

Other media mentions: 

Link to La Vanguardia

Link to Agencia SINC

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).